Have Quicker and More Effective Approaches Arrived for Eradicating Hepatitis C?
Share
Follow Us
The Editors at Hepatitis Central
October 23, 2013
Two Hepatitis C drugs the FDA is reviewing have the potential to increase cure rates for the liver virus. Discover more about the experimental medications from Johnson & Johnson and Gilead Sciences, called simeprevir and sofosbuvir.
FDA reviews 2 promising new drugs for hepatitis C
Tuesday, October 22, 2013
By: Associated Press
WASHINGTON — Doctors may soon have two new drug options for patients with hepatitis C, just as the liver-destroying virus becomes a major public health concern for millions of baby boomers.
The Food and Drug Administration holds a public meeting this week to review two experimental medications from Johnson & Johnson and Gilead Sciences. The new drugs, if approved, could offer a quicker, more effective approach to eliminating hepatitis C, a blood-borne disease blamed for 15,000 deaths in the U.S. this year.
Continue reading this entire article:
http://bostonherald.com/business/healthcare/2013/10/fda_reviews_2_promising_new_drugs_for_hepatitis_c
